How BioSig Technologies (BSGM) Is Positioned To Change the Electrophysiology Market

April 1, 2016 - PRLog -- BioSig Technologies, Inc. (BSGM) is a Minnesota-based medical device company developing a proprietary technology platform designed to improve the rapidly growing multi-billion dollar electrophysiology (EP) marketplace. The company's leading product is Pure EP™, a surface electrocardiogram (EKG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists during catheter ablation procedures to treat cardiac arrhythmia. Pure EP is comprised of proprietary hardware and software that acquires and displays high-fidelity cardiac signal recordings. By providing precise, uninterrupted, real-time evaluations of EKG and electrogram data, Pure EP improves the clinical decision-making process by the electrophysiologists in the EP lab. Quite simply, Pure EP results in better cardiac mapping and ablation point targeting, which can lead to reduced cost and superior outcomes for patients with arrhythmia.

Below is an introduction to BioSig Technologies and a teach-in on the EP market, including a review of cardiac arrhythmia and ablation procedures. I see the company as incredibly undervalued based on the expected growth in the EP market over the next decade, and believe that the company's superior technology platform is a credible threat in an industry segment dominated by some of the world's largest players, including Boston Scientific, St. Jude Medical, Abbott Labs, Johnson & Johnson, and GE Healthcare; all of which have a history of acquiring smaller EP players with potential disruptive technology. Beyond this potential obvious exit strategy, BioSig has partnered with some of the country's leading cardiac centers, including the Texas Cardiac Arrhythmia Institute, UCLA Cardiac Arrhythmia Center, U.H. Case Medical Center in Cleveland, William Beaumont Hospital in Michigan, Mount Sinai Medical Center in NY, and the Mayo Clinic in Minnesota to generate clinical data and validate proof-of-concept with Pure EP. Finally, the company is run by what looks to be an outstanding leadership team of experienced industry executives, renowned cardiac electrophysiologists, and astute entrepreneurs.

Please read the full story here >> http://www.bionapcfa.com/2016/03/how-biosig-technologies-...